2021 annual financial data
Rhythm Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was -5,391.85%.
Operating income was -170,059,000 USD and net income was -68,007,000 USD.
Operating cash flow was -146,003,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,154,000 USD
- Operating income
- -170,059,000 USD
- Net income
- -68,007,000 USD
- Operating cash flow
- -146,003,000 USD